These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 11800503

  • 41. A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia.
    Katona CL, Hunter BN, Bray J.
    Int J Geriatr Psychiatry; 1998 Feb; 13(2):100-8. PubMed ID: 9526179
    [Abstract] [Full Text] [Related]

  • 42. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
    Möller HJ, Berzewski H, Eckmann F, Gonzalves N, Kissling W, Knorr W, Ressler P, Rudolf GA, Steinmeyer EM, Magyar I.
    Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
    Fava M, Amsterdam JD, Deltito JA, Salzman C, Schwaller M, Dunner DL.
    Ann Clin Psychiatry; 1998 Dec; 10(4):145-50. PubMed ID: 9988054
    [Abstract] [Full Text] [Related]

  • 46. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 47. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA.
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
    Möslinger-Gehmayr R, Zaninelli R, Contu A, Oberhoff C, Gutschow K, Schindler AE, Staab HJ.
    Zentralbl Gynakol; 2000 May; 122(4):195-202. PubMed ID: 10795116
    [Abstract] [Full Text] [Related]

  • 51. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
    Samuelian JC, Hackett D.
    J Psychopharmacol; 1998 May; 12(3):273-8. PubMed ID: 10958254
    [Abstract] [Full Text] [Related]

  • 52. Paroxetine and amitriptyline in the treatment of depression in general practice.
    Christiansen PE, Behnke K, Black CH, Ohrström JK, Bork-Rasmussen H, Nilsson J.
    Acta Psychiatr Scand; 1996 Mar; 93(3):158-63. PubMed ID: 8739658
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder.
    Ratti E, Bellew K, Bettica P, Bryson H, Zamuner S, Archer G, Squassante L, Bye A, Trist D, Krishnan KR, Fernandes S.
    J Clin Psychopharmacol; 2011 Dec; 31(6):727-33. PubMed ID: 22020354
    [Abstract] [Full Text] [Related]

  • 58. Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study.
    Sechter D, Peuskens J, Fleurot O, Rein W, Lecrubier Y, Amisulpride Study Group.
    Neuropsychopharmacology; 2002 Dec; 27(6):1071-81. PubMed ID: 12464464
    [Abstract] [Full Text] [Related]

  • 59. Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group).
    Carrière P, Bonhomme D, Lempérière T.
    Eur Psychiatry; 2000 Aug; 15(5):321-9. PubMed ID: 11032464
    [Abstract] [Full Text] [Related]

  • 60. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M, Barg T, König F, Leibfarth M, Grünewald I.
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.